EnteroMedics Secures a $45 Million Committed Issuer Managed Equity Financing Facility With Terrapin Opportunity, L.P.
[at noodls] – ST. PAUL, MN — (Marketwire) — 10/04/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … more
View todays social media effects on ETRM
View the latest stocks trending across Twitter. Click to view dashboard